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Background: Bloodstream infection (BSI) is one of the significant causes of morbidity and
mortality encountered in a neonatal intensive care unit, especially in developing countries.
Despite the implementation of infection control practices, such as strict hand hygiene, the
BSI rate in our hospital is still high. The use of a closed catheter access system to reduce
BSI related to intravascular catheter has hitherto never been evaluated in our hospital.
Objective:To determine the effects of closed catheter access system implementation in
reducing the BSI rate in preterm neonates with low birth weight.
Methods: Randomized clinical trial was conducted on 60 low birth weight preterm infants
hospitalized in the neonatal unit at Cipto Mangunkusumo Hospital, Jakarta, Indonesia from
June to September 2013. Randomized subjects either received a closed or non-closed
catheter access system. Subjects were monitored for 2 weeks for the development of BSI
based on clinical signs, abnormal infection parameters, and blood culture.
Results: Closed catheter access system implementation gave a protective effect toward
the occurrence of culture-proven BSI (relative risk 0.095, 95% CI 0.011–0.85, p=0.026).
Risk of culture-proven BSI in the control group was 10.545 (95% CI 1.227–90.662,
p=0.026). BSI occurred in 75% of neonates without risk factors of infection in the control
group compared to none in the study group.
Conclusion: The use of a closed catheter access system reduced the BSI in low birth
weight preterm infants. Choosing the right device design, proper disinfection of device,
and appropriate frequency of connector change should be done simultaneously.
Keywords: bloodstream infection, central line-associated bloodstream infection, closed catheter access system,
preterm infants, infection control practices, needleless connector
INTRODUCTION
Bloodstream infection (BSI) remains a major problem which is
encountered in neonatal care, especially in developing countries.
Low birth weight (LBW) preterm infants are specifically more
susceptible to BSI during hospitalization due to a higher require-
ment of vascular lines for administration of parenteral nutrition,
blood products, or intravenous medications (1–3). Central line-
associated bloodstream infection (CLABSI) is a major cause for
longer hospital stay, increased hospital costs, and the high mor-
tality rate of neonatal intensive care unit (NICU) patients. The
CLABSI is reported to cause up to 70% of all HAI (hospital-
acquired infection)-BSI in preterm infants (4, 5). The National
Healthcare Safety Network (NHSN) in 2009 reported a CLABSI
rate of 1.3–3.4 BSIs per 1000 catheter days, and this rate decreased
in 2010 to 0.8–2.6 BSIs per 1000 catheter days (6, 7). NICUs in
developing countries such as Brazil reported a higher BSI rate
of 17.3 BSIs per 1000 catheter days in 2010 (8), while India
noted a much higher rate of 27 BSIs per 1000 catheter days in
2011 (9). In comparison, in year 2012 the neonatal unit of Cipto
Mangunkusumo Hospital (CMH) in Jakarta, Indonesia reported a
BSI rate of 12.88 per 1000 catheter days, and then a slight decrease
in 2013 to 10.53 BSIs per 1000 catheter days (10).
Recent studies have identified that CLABSI is largely pre-
ventable (4, 11). Several practices, such as hand washing, proper
catheter insertion practices, maximal barrier precautions, cleaning
the skin with chlorhexidine, and avoiding femoral site combined
with timely removal of the catheter, reduced significantly the
CLABSI rate from 7.7 to 1.4 per 100 catheter days in adult patients
treated in intensive care unit (ICU) (12). Specifically for neonatal
care, CLABSI prevention efforts must emphasize both sterile cen-
tral line insertion techniques and rigorous attention to ongoing
central line care and maintenance (4). The term of closed catheter
access system is used interchangeably with a needleless connec-
tor (NC) system, which was previously developed for preventing
needlestick injury. The Center for Disease Controls (CDC) and
other research have shown that the closed catheter access system
is effective in reducing CLABSI through preventing the entry of
microorganisms to the vascular access (6, 7, 13–16). Although
CDC (2011) recommended the needleless system to access intra-
venous (IV) tubing (16), it is not yet officially implemented as the
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standard policy in the neonatal unit of our hospital. The aim of
this study was to evaluate the effects of closed catheter access sys-
tem implementation in reducing the BSI rate in low birth weight
preterm infants in CMH.
MATERIALS AND METHODS
STUDY DESIGN AND SAMPLING METHOD
Randomized controlled trial (RCT) was conducted in the NICU
and special care nursery (SCN) of CMH from June to Septem-
ber 2013. All neonates born in CMH with gestational age under
37 weeks and a birth weight less than 2500 g who required vascu-
lar access (peripheral and/or central) insertion were included in
the study. Informed consents were taken from the parents prior
to recruitment. Patients with severe diseases who might not live
more than 72 h, such as complex congenital heart disease, chro-
mosomal abnormalities, or babies in critical conditions at birth
were excluded. Sixty subjects were enrolled and randomized using
a block randomization method to either receive closed catheter
access system (intervention group) or non-closed system (con-
trol group). All subjects were monitored for 2 weeks for signs and
symptoms of BSI due to limited funding from research grant of
our hospital. Subjects showing signs of new episodes of HAI-BSI
underwent laboratory assessment and blood culture tests for BSI
diagnosis confirmation.
INFECTION CONTROL PRACTICES IN CMH
Cipto Mangunkusumo Hospital has been working in conjunction
with SEA-URCHIN (South-East Asia-Using Research for Change
in Hospital-Acquired Infection in Neonates) project, between Aus-
tralia and four South-East Asian countries. Since June 2013, our
unit has been conducting regular infection control practices train-
ing according to the materials received from the Australian team.
The training includes proper hand hygiene, hospital infection con-
trol practices, central line insertion and care, and antibiotic policy.
Preparation of total parenteral nutrition, solution, and medica-
tion are done under laminar airflow in the pharmacy department
of CMH, and quality monitoring has been regularly conducted
since 2006. Oral nystatin prophylaxis has been given since the year
of 2012 for babies <1500 g and/or <32 weeks who have risk factors
of getting systemic fungal infection.
STANDARD PROCEDURE DURING THE STUDY
The peripheral venous line was indicated for the administration
of fluid and medication through a short intravenous catheter. The
peripheral intravenous cannula may be maintained for up to 5 days
when there was no sign of local infection or phlebitis. Every vascu-
lar line insertion and change must maintain an aseptic/no touch
technique. Central venous line was implemented by inserting the
umbilical catheter or peripherally inserted central catheter (PICC).
The umbilical catheter was maintained for no more than 5 days. A
peripheral insertion central catheter was used when oral intake was
inadequate for at least 7 days or if the total parenteral nutrition was
required for more than 1 week. Total parenteral nutrition (TPN)
administration was given through a central line, whereas medica-
tion or other fluids were given through a peripheral line to ensure
minimal line breaks. The central line was removed when CLABSI
was suspected and the infant’s condition did not improve after
antibiotic therapy, or if there were signs of inflammation at the
catheter insertion site. If the entry site was inflamed and/or there
was phlebitis, each intravenous set must be changed. Every TPN
bag or lipid change in the central line must be done under maximal
barrier precaution. In the peripheral and central lines before the
connection of the intravenous line, the catheter hub or three-way
stopcock must be vigorously scrubbed using a 70% alcohol swab
twice for a total of 20 s (consideration for 20 s of swabbing dura-
tion was based on SEA-URCHIN training), and the antiseptic has
to be dry for 30 s. During the 2- week study period, the adminis-
tration sets in both groups and the NCs in the closed system were
changed every 48 h for practical purposes in accordance to the
changing of the TPN bag. There were no differences in principles
for line insertion and change between both the intervention and
control groups. All preparations to insert peripheral and central
line, sterile insertion technique and line changes, and maintenance
of central line care were done according to SEA-URCHIN training.
CLOSED CATHETER ACCESS SYSTEM
The closed catheter access system was used in the periph-
eral venous line, central venous line, and arterial line (see
Figures 1A–3A). The system was used for intravenous medica-
tion and TPN through a needleless connector and male luerlock.
Administration sets consisted of an extension tube, syringe, and/or
infusion set using the luerlock system to prevent the outflow of
fluid through the connector (16). SmartSite®/Surplug® (Surplug®
using SmartSite® manufactured by ALARIS Medical Systems, is
a trade mark of Terumo corporation, Japan) was the needleless
connector used in our study. This NC is a split septum (SS) and
mechanical valve (MV) type. When the male luer is attached, it
opens the sides of the SS. Therefore, the fluid pathway is opened
to allow the administration of fluid. Removing the male luer tip
automatically returns to its closed position and returns the fluid
pathway to its original position (see Figure 4).
NON-CLOSED CATHETER ACCESS SYSTEM
This system used a slip tip port and three-way stopcock as our
current practice (see Figures 1B–3B).
DEFINITIONS
Central line-associated bloodstream infection is a form of pri-
mary BSI and not related to another site of infection (16, 18). In
this study, CDC guidelines to diagnose CLABSI were used, which
is laboratory-confirmed bloodstream infection (LCBI) in patients
with a central line placed for >2 days prior to the occurrence of
clinical symptoms (19). Presumed sepsis was defined as the pres-
ence of clinical signs of sepsis in the normal full blood count,
C-reactive protein (CRP) and immature to total neutrophil (IT)
ratio, and absence in micro-organism growth in blood culture.
Probable sepsis was defined as a neonate suspected clinically to
have sepsis with CRP >6 mg/dL and at least one of the follow-
ing rapid diagnostic tests recorded positive: thrombocytopenia
(<150,000/µL), IT ratio >0.2, white blood count <5000/µL or
>30,000/µL (first week)/>15,000/µL (after the second week),
the blood culture was negative. Culture-proven BSI was defined
as a neonate showing clinical signs of sepsis with an abnormal
laboratory result as above and a positive blood culture (20).
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FIGURE 1 | (A) Intervention: peripheral line in the closed catheter access system. 1. Intravascular cannula, 2. Single needleless connector, 3. Double lumen NCs
with luer lock, 4. Extension tube luer lock, 5. Luer lock syringe. (B) Control: peripheral line in the open system. 1. Intravascular cannula, 2. Extension tube slip tip,
3. Three-way stopcock, 4. Slip tip syringe.
FIGURE 2 | (A) Intervention: central line in the closed catheter access
system. 1. Peripherally inserted central catheter, 2. Single needleless
connector, 3. Triple lumen NCs with luer lock, 4. Extension tube luer lock
(black), 5. Luer lock syringe 50 mL (black), 6. Infusion set luer lock, 7.Total
parenteral nutrition bag, 8. Extension tube luer lock, 9. Luer lock syringe.
(B) Control: central line in the open system. 1. Peripherally inserted
central catheter, 2. Three-way stopcock, 3. Carbon-coated extension
tube slip tip, 4. Carbon-coated syringe (lipid), 5. Infusion set slip tip, 6.
Total parenteral nutrition bag, 7. Extension tube slip tip, 8. Slip tip
syringe.
Signs and symptoms of BSI were defined at least one of the fol-
lowing signs or symptoms: fever (>38°C), hypothermia (36°C),
apnea, or bradycardia (16).
Maternal risk factors were defined as the presence of otherwise
unexplained maternal fever greater than 38°C with at least two
of the following additional clinical findings: maternal tachycar-
dia (>100 bpm), fetal tachycardia (>160 bpm), elevated maternal
white blood cell count (>15,000 cells/µL), uterine tenderness, and
foul smelling amniotic fluid (21).
STATISTICAL ANALYSIS
All the statistical analysis were conducted using SPSS version 22.0
(Chicago, IL, USA). Analysis was conducted to compare the two
groups with respect to gender, gestational age, birthweight, mater-
nal risk factor of infection, clinical signs of infection, and mortality
rate in 2 weeks. Chi-square and Fisher’s exact tests were used. p
Value of <0.05 was considered as statistically significant. This
study was approved by the Ethics Committee of the Faculty of
Medicine, University of Indonesia.
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FIGURE 3 | (A) Intervention: arterial line in the closed catheter access
system. 1. Intravascular cannula, 2. Extension tube luer lock, 3. Three-way
stopcock luer lock, 4. Needleless connector, 5. Heparin saline in luer lock
syringe. (B) Control: arterial line in the open catheter access system. 1.
Intravascular cannula, 2. Extension tube slip tip, 3. Three-way stopcock, 4.
Heparin saline in slip tip syringe.
FIGURE 4 | Left: SmartSite®. Center and right: fluid path mechanism (17).
RESULTS
The study recruited a total of 60 low birth weight infants, consist-
ing of 30 infants in each group. No surgical baby was recruited.
Both groups did not differ significantly in terms of gender, gesta-
tional age, maternal risk factors for infection, and mortality rate
in 2 weeks (Table 1).
The incidence of culture-proven BSI in the intervention group
was significantly lower than that of the control group (3.3 vs.
26.7%, p= 0.026, Table 2). The most common organisms in both
groups were Acinetobacter baumanii (n= 5), followed by Panthoea
sp. (n= 2), and Candida parapsilosis (n= 2).
Chi-square statistical test results showed that a closed catheter
access system implementation gave a protective effect toward
culture-proven BSI (relative risk 0.095, 95% CI 0.011–0.85,
p= 0.026). The control group had a 10.545 times higher risk of BSI
compared to the study group (95% CI 1.227–90.662, p= 0.026,
Table 2). The closed catheter access system also prevented the
occurrence of presumed BSI (clinical signs of infection) with
relative risk of 0.203 (95% CI 0.066–0.620, p= 0.004, Table 3). A
similar result was also found in the probable BSI (clinical signs of
infection followed by abnormal infection parameters) with relative
risk of 0.203 (95% CI 0.066–0.62, p= 0.008, Table 3).
During 2-week of observation, both groups showed a differ-
ence in average sepsis episodes. The repeated culture-proven BSI
incidence increased significantly in the control group. (p= 0.038).
Two infants in the control group had two sepsis episodes and one
infant had three sepsis episodes compared to no multiple sepsis
episodes in the study group.
Among the 10 infants without maternal risk factors of infection
(six in the study group and four in the control group), BSI occurred
in 75% of infants in the non-closed catheter access system group
compared to none in the study group (Table 4).
DISCUSSION
Low birth weight infants are vulnerable to BSI due to their imma-
ture immune system, prolonged hospital stay, and high exposure
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Table 1 | Baseline characteristics of subjects.
Intervention
(n=30)
Control
(n=30)
Sex, n (%)
Male 14 (46.7%) 13 (43.3%)
Female 16 (53.3%) 17 (56.7%)
Gestational age, mean
(SD) weeks
32.4 (SD 1.81) 32.6 (SD 2.1)
Birth weight, mean (SD)
grams
1582 (SD 283.4) 1648.17 (SD 343.23)
Maternal risk factors of
infection, n (%)
Yes 24 (80%) 26 (86.7%)
No 6 (20%) 4 (13.3%)
Death, n (%) 1 (3.33%) 1 (3.33%)
SD, standard deviation.
Table 2 | Culture-proven BSI occurrence in both groups.
No BSI BSI Total p
Intervention 29 (96.7%) 1 (3.3%) 30 0.026*
Control 22 (73.3%) 8 (26.7%) 30
Total 51 9 60
*Chi-square test.
Table 3 | Presumed and probable BSI occurrence in both groups.
Not BSI BSI Total p
Presumed BSI
Intervention 17 (56.7%) 13 (43.3%) 30 0.004*
Control 7 (23.3%) 23 (76.7%) 30
Probable BSI
Intervention 23 (76.7%) 7 (23.3%) 30 0.008*
Control 12 (40.0%) 18 (60.0%) 30
*Chi-square test.
Table 4 | BSI in infants without previous infection.
Not Sepsis Sepsis Total p
Intervention 6 (100%) 0 (0%) 6 (100%) 0.033*
Control 1 (25%) 3 (75%) 4 (100%)
*Fisher’s exact test.
to invasive interventions (22–24). One of the most common
interventions is vascular line insertion to administer medications
and total parenteral nutrition. Several studies have shown that
peripheral and central vein catheter insertion have similar risks
for the occurrence of sepsis (22, 25).
A stopcock has been used in global medical practices, includ-
ing in CMH. However, the stopcock is a potential portal of entry
for microorganisms into vascular access catheters and IV fluids
(16). On the other hand, the needleless intravascular catheter
system was initially developed for the purpose to prevent the
incidence of needlestick injury to healthcare personnel and the
system was found to be more effective in reducing the risk for
transmission of bloodborne infections compared to the stopcock
(16, 26). Guidelines for the Prevention of Intravascular Catheter-
Related Infections issued by CDC in 2011 recommended the use
of the needleless intravascular catheter system with the key points
including the needleless components and administration sets are
changed no more frequently than every 72 h. All components
used must be compatible to minimize leaks and breaks in the
system, scrubbing the access port with an appropriate antiseptic,
also accessing the port only with sterile devices (16). During the
2-week study period, change of the administration set and the NCs
was conducted every 48 h for practical purposes in accordance to
changing the TPN bag. According to CDC recommendation, the
policy to change the connectors every 48 h was unnecessary (16).
The study results showed that the use of the closed catheter access
system gave a protective effect toward culture-proven BSI; this was
similar to other studies (13–15, 22).
Furthermore, another important factor which contributes to
zero CRBSI is appropriate device design (27). There are several
types of needleless connectors on the market, which have differ-
ent mechanisms of access, access portal, flow path, and the fluid
displacement (17, 27). This study used Smartsite®/Surplug® with
a SS as its access portal and a MV with a negative fluid displace-
ment (NFD). The main reason to choose Smartsite®/Surplug® in
this study is due to its comparatively lower price. There are four
NCs available in Indonesia, three NCs are NFD type, and one
is neutral fluid displacement (NeuFD) type. Other NCs’ prices
are two- to three-fold more expensive than Smartsite®/Surplug®.
CDC recommended the use of a SS valve as an access portal over
some MVs due to the increased risk of infection with the MVs
(16). While the Society for Healthcare Epidemiology of Amer-
ica (SHEA) and Infectious Diseases Society of America (IDSA)
advised not to use positive fluid displacement (PFD) mechanical
valve-needleless connector (MV-NCs) routinely due to high infec-
tion rate, Jarvis et al. in 2009 recommended the avoidance should
also include NFD MV-NCs as well (27–29). However, a review
from Canadian Agency for Drugs and Technologies in Health
(CADTH) showed there were no differences between NFD and
PFD type in terms of catheter-related infections based on three
RCTs and one of the observational studies showed that the PFD-
MV type was associated with more CRBSI than the NFD type (30).
In addition, the Smartsite® had been reported to have less bacter-
ial transfer than other connector designs (27). The results of this
research also showed that the use of the closed catheter access sys-
tem gave a protective effect toward culture-proven BSI, regardless
of the use of NFD.
Most MV-NCs are opaque, making it difficult to see inside
to determine if there is any residual of blood, nutritional fluid
remains, or there is debris remaining inside (17, 28). Ryder
reported there was no significant difference of bacterial trans-
fer and biofilm formation on the intraluminal catheter surface
between Clearlink® (clear device) and Smartsite® (31). Besides
that, the external surface of NC maybe associated with infec-
tion risk. The needleless connector may have some surface
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configurations, such as: flat, angled post in the center, or irregular
form, and also with or without a new sterile end cap. The more
complicated designs made if difficult to swab the surface ade-
quately before use (17). The Smartsite® has a flat and easy swab
surface, so that the health personnel would easily be able to clean
the surface before manipulation.
Esteve et al. (32) reported a different result about Smartsite®
that it did not reduce the incidence of catheter-related bacteremia
in adult patients of the ICU. In their study, there was a different
treatment between two groups; NCs were disinfected with 0.5%
chlorhexidine digluconate solution, while there was no swabbing
on the three-way stopcocks (32). Another prospective study with a
different result was Salgado et al. (33) in a medical facility for adult
patients with long-term hospitalization. This study concluded that
the use of NFD-NC switched from a needleless split-septum device
(NSSD) could increase CRBSI. In their study, the connector was
changed every 96 h, unless there were blood products or parenteral
nutritions administered and only swabbed 3–5 s before manipu-
lation (33). Method differences between Salgado’s study and this
study may give different results. Ryder et al. (31) compared the bac-
terial transfer rate of eight NCs. This study inoculated bacteria on
the surface of NC twice a day and dried for 30 min before attach-
ing to the catheter. The connector-catheter sets were flushed with
sterile normal saline, collected, then plated. The result showed that
NeuFD NC had the smallest mean log densities (LD) surface inoc-
ulation compared with others (31). However, until now no studies
have been found which compare the NCs type in newborn infants.
The implementation of the proper aseptic device management
in this study is ensured. The time duration of antiseptic swab-
bing is not mentioned in the CDC recommendation. This studies’
consideration for 20 s of swabbing duration was based on SEA-
URCHIN training. A study conducted by Rupp et al. (34) showed
no significant difference in microbial contamination rates among
5-, 10-, 15-, and 30-s of disinfection time. The study concluded
that a 5 s scrub with 70% isopropyl alcohol gives adequate dis-
infection of a split-septum intravascular catheter. Nevertheless,
in vitro assessment by Rupp et al. reported that the connector
valves should be disinfected≥10 s to sterilize very heavy contami-
nation (10 8 CFU per connector diaphragm) (34). Similarly, other
studies have recommended routine disinfection of catheter con-
nector valves for 15 s or longer (6, 35, 36). The choice of antiseptic
in CDC is chlorhexidine, povidone iodine, an iodophor, and 70%
alcohol (16). Kaler et al. in 2007 reported that alcohol alone or alco-
hol based chlorhexidine is equally effective in sterilizing NC with
15 s swabbing duration, regardless of whether NCs are negative,
positive, or neutral fluid displacement type (37). The decision to
use 70% isopropyl alcohol in the CMH unit is because it is broadly
effective against a wide variety of bacterial and fungal pathogens
and also is inexpensive and easily available (34, 37).
The limitations in this study are the limited number of subjects
without risk factors of infection and the short follow-up time. In
this study, it was shown that the majority of subjects (75%/three
out of four infants) without risk factors of infection in the con-
trol group had sepsis during 2 weeks of observation, while none
was infected in the study group. However, this percentage may
not represent the same probability for all subjects without risk
factors of infection. To date, there are still a small number of
studies regarding the use of SS-negative fluid displacement design
globally, and none in Indonesia. This study is the first internal
Indonesian study regarding the use of the needleless catheter sys-
tem. Another study conducted with a bigger number of subjects
without risk factors of infection especially with same device design
(NFD-NCs) is encouraged.
In conclusion, our study showed that the NCs/closed catheter
system reduced the CRBSI rate compared to the non-closed
catheter access system. Furthermore, in order to maintain lower
CRBSI rate not only the right choice of device design, but also the
disinfection of access port and frequency of administration sets
should be done properly and at the same time.
The encouraging results of this study hopefully will add to
the knowledge of medical providers and policy makers regarding
the closed catheter access system as the possible intervention to
reduce BSI rate. Although the cost spending for the use of NCs
in this study, advantages gained by using the system outweigh the
potential higher cost due to longer hospital stay in case of BSI
occurrence.
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